FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2566952017> ?p ?o ?g. }

• W2566952017 endingPage "A129" @default.
• W2566952017 startingPage "A129.1" @default.
• W2566952017 abstract "<h3>Introduction</h3> Focus on quality assurance in colonoscopy intensified as a prequel to the launch of the UK National Bowel Cancer Screening Programme. Previous research has examined auditable standards such as caecal intubation rate, adenoma detection and major complications but much less is known about the prevalence of post-discharge symptoms which may be self-limiting and not require readmission or formal medical input. <h3>Aim</h3> To determine the prevalence of post-discharge symptoms in patients that underwent colonoscopy and the possible causal associations. <h3>Methods</h3> As part of our Quality Assurance audit programme, a structured telephone survey was administered to 514 patients who had undergone colonoscopy (with air insufflation) at our University Hospital (July 07–Oct 08). The survey consisted of questions regarding overall experience, procedure comfort, intravenous cannula site problems, and post-discharge symptoms of; bleeding, nausea and vomiting, bloating and pain. Demographics, colonoscopy details and interview responses were collated. Characteristics of a “symptomatic group” (reporting any pain, bloating or n/v) (“SympGp”) were compared with “asymptomatic group” (“AsympGp”) and results expressed as either per cent or mean (SD). <h3>Results</h3> Overall prevalence: IV site symptoms: 6%; PR bleeding: 5.4%; Nausea or Vomiting: 0.6%; Bloating: 11%; Pain: 9.5%. 100 patients (19.5%) reported one or more symptoms of pain, bloating, nausea or vomiting (SympGp). Predictably, SympGp rated their overall experience (1–10 point scale: 10=best score) less favourably (7.5 (2.4) vs 8.1 (2.3), p=0.04) and their comfort during procedure (1–5 scale; 1=best score) was lower (2.4 (1.3) vs 1.9 (1.1), p=0.001). SympGp were more often female (55% vs 43.5%) and were younger (58 vs 64 years, p<0.0001). However, the ASA score, trainee involvement, therapy rates and procedure times were not significantly different from the AsympGp (p>0.05). Midazolam doses used were higher in the SymptGp (2.1 mg (1.3) vs 1.7 mg (1.2), p=0.03), but Fentanyl doses were similar (p=0.18). <h3>Conclusion</h3> Post-discharge symptoms are not uncommon with almost 1:16 experiencing cannula site symptoms, 1:20 bleeding and 1:5 symptoms of nausea/vomiting, pain or bloating. These latter patients had more procedure discomfort and less favourable overall experience despite larger doses of sedation. Younger, female patients were more likely to report post-discharge symptoms but trainee involvement, therapy, IV opiate administration and procedure time had no effect. Given the prevalence of these symptoms, repeating a similar audit using CO2 insufflation would be interesting." @default.
• W2566952017 created "2017-01-06" @default.
• W2566952017 creator A5036111873 @default.
• W2566952017 creator A5071544771 @default.
• W2566952017 creator A5089680660 @default.
• W2566952017 date "2010-04-01" @default.
• W2566952017 modified "2023-09-26" @default.
• W2566952017 title "PTH-016 Prevalence of post-discharge symptoms following colonoscopy and possible causal associations: quality assurance audit with telephone survey in 514 patients" @default.
• W2566952017 doi "https://doi.org/10.1136/gut.2009.209023c" @default.
• W2566952017 hasPublicationYear "2010" @default.
• W2566952017 type Work @default.
• W2566952017 sameAs 2566952017 @default.
• W2566952017 citedByCount "0" @default.
• W2566952017 crossrefType "journal-article" @default.
• W2566952017 hasAuthorship W2566952017A5036111873 @default.
• W2566952017 hasAuthorship W2566952017A5071544771 @default.
• W2566952017 hasAuthorship W2566952017A5089680660 @default.
• W2566952017 hasConcept C121608353 @default.
• W2566952017 hasConcept C126322002 @default.
• W2566952017 hasConcept C1862650 @default.
• W2566952017 hasConcept C2776956441 @default.
• W2566952017 hasConcept C2778435480 @default.
• W2566952017 hasConcept C2778541695 @default.
• W2566952017 hasConcept C2780580376 @default.
• W2566952017 hasConcept C2780852908 @default.
• W2566952017 hasConcept C526805850 @default.
• W2566952017 hasConcept C71924100 @default.
• W2566952017 hasConceptScore W2566952017C121608353 @default.
• W2566952017 hasConceptScore W2566952017C126322002 @default.
• W2566952017 hasConceptScore W2566952017C1862650 @default.
• W2566952017 hasConceptScore W2566952017C2776956441 @default.
• W2566952017 hasConceptScore W2566952017C2778435480 @default.
• W2566952017 hasConceptScore W2566952017C2778541695 @default.
• W2566952017 hasConceptScore W2566952017C2780580376 @default.
• W2566952017 hasConceptScore W2566952017C2780852908 @default.
• W2566952017 hasConceptScore W2566952017C526805850 @default.
• W2566952017 hasConceptScore W2566952017C71924100 @default.
• W2566952017 hasIssue "Suppl 1" @default.
• W2566952017 hasLocation W25669520171 @default.
• W2566952017 hasOpenAccess W2566952017 @default.
• W2566952017 hasPrimaryLocation W25669520171 @default.
• W2566952017 hasRelatedWork W2048461020 @default.
• W2566952017 hasRelatedWork W2063277504 @default.
• W2566952017 hasRelatedWork W2082044892 @default.
• W2566952017 hasRelatedWork W2084908394 @default.
• W2566952017 hasRelatedWork W2102336024 @default.
• W2566952017 hasRelatedWork W2330817593 @default.
• W2566952017 hasRelatedWork W2428050932 @default.
• W2566952017 hasRelatedWork W2921318935 @default.
• W2566952017 hasRelatedWork W3028976792 @default.
• W2566952017 hasRelatedWork W3047452080 @default.
• W2566952017 hasVolume "59" @default.
• W2566952017 isParatext "false" @default.
• W2566952017 isRetracted "false" @default.
• W2566952017 magId "2566952017" @default.
• W2566952017 workType "article" @default.